New Fund Offer Updates

Company  HDFC Asset Management Company Limited
Scheme Name  HDFC Pharma and Healthcare Fund-Reg(G)
Scheme Type  Open ended scheme
Benchmark Index  S&P BSE Health Care - TRI
Fund Manager  Nikhil Mathur
Category  Equity - Sectoral Fund - Pharma & Health Care
Initial Offer Price ()  10
Minimum Investment ()  100
Additional Investment ()  100
Objective  To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Max Entry Load%:  
Max Exit Load%:  1
Option Type  Growth, IDCW

Investment Pattern

Equity and Equity related instruments of Pharma and Healthcare companies80100
Units of MF020
Debt securities, Money Market Instruments and Fixed Income Derivatives020
Equity and Equity related instruments of companies other than above020
Units of REITs and InvITs010

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)



  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.


1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.